# Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye

> **NCT00621439** · NA · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Ocular Melanoma

## Interventions

- **DRUG:** Pegylated Interfon Alpha 2B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00621439
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-03
- **Primary completion:** 2008-06
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no funding- study never began
- **Last updated:** 2013-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621439, "Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT00621439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*